血管内支架市场－全球产业规模、份额、趋势、机会、预测：按类型、产品、最终用途、地区和竞争格局划分，2021-2031年

全球血管内支架市场预计将从 2025 年的 132.2 亿美元成长到 2031 年的 202.8 亿美元，在此期间的复合年增长率为 7.39%。

这些装置是可扩张的网状管，用于重新开通狭窄或阻塞的动脉，对于恢復血流和确保血管通畅性至关重要。成长要素的关键因素包括全球人口快速老化和心血管疾病发病率的上升，这导致对冠状动脉疾病等疾病的介入治疗需求增加。根据欧洲心臟学会的数据，到2024年，心血管疾病每年在成员国造成的死亡人数将超过300万，凸显了对有效治疗方案的迫切需求。

另一方面，它们也面临来自严格的安全标准和产品核可法规结构的重大障碍。监管机构要求进行全面的临床试验，这延长了医疗设备进入商业市场前的研发週期，并增加了生产成本。此外，由于血栓症等不利事件导致的产品召回风险，将对品牌声誉构成严重威胁，并可能延缓新兴技术的市场推广。

市场驱动因素

全球心血管疾病发生率的上升趋势是血管内支架产业的主要驱动力，因为需要进行更多血管成形术来治疗动脉阻塞。随着不健康饮食习惯和久坐生活方式的日益普遍，冠状动脉疾病的发生率不断上升，需要进行机械介入以维持足够的血流。根据美国疾病管制与预防中心 (CDC) 于 2025 年 9 月发布的《关键统计快报》，心臟病仍将是 2024 年的首要死因，仅在美国就报告了 683,037 例死亡。这一持续存在的健康问题导致了对治疗器械的稳定需求，而这一趋势也反映在了该行业的表现中。Medtronic于 2025 年 6 月发布的《2025 财年年度报告》显示，其心血管产品组合的净销售额为 125 亿美元，凸显了这些治疗方法的全球重要性。

此外，支架材料和设计方面的技术创新也是成长要素，製造商不断推出新一代产品，以加速患者康復并扩大适用患者范围。药物释放型技术和生物可吸收支架等技术的进步，与传统的裸金属支架相比，显着降低了血栓症和血管再阻塞的风险，使医生能够治疗以往难以处理的周边血管疾病和复杂病变。持续的研发投入正为主要企业带来丰厚的回报。例如，雅培公司于2025年1月发布的「2024年第四季及全年财务业绩」显示，其医疗设备，以维持收入成长和市场发展势头。

市场挑战

严格的安全标准和产品核可法律规范对全球血管内支架市场的扩张构成重大障碍。世界各地的监管机构都对品质保证和临床试验提出了严格的要求，製造商必须满足这些要求才能将产品商业化。这些繁琐的要求显着延长了产品研发週期，增加了财务成本，常常迫使企业将资金从研发投入转移出去。这种复杂的法规环境减缓了创新支架技术的应用，并限制了其在关键地区的使用。

根据欧洲医疗技术协会（MedTech Europe）2024年的数据，在新监管环境下，医疗设备认证的平均时间已延长至13-18个月，合规成本较以往指令增加了约100%。这些延误和成本增加迫使製造商重新评估其市场策略，往往导致旧产品下架，以及在监管障碍较高的地区降低优先顺序。因此，核准流程的停滞直接阻碍了市场成长，并限制了心血管疾病患者及时获得先进治疗方案的机会。

市场趋势

在医疗保健成本效益需求和不断变化的报销政策的推动下，手术向门诊手术中心 (ASC) 的转移正在从根本上改变采购环境。医疗系统正在加速将经经皮冠状动脉介入治疗 (PCI) 从住院环境转移到门诊环境，以降低手术成本并缓解医院容量问题。这项转变的驱动因素包括监管政策的变化，例如美国医疗保险和医疗补助服务中心 (CMS) 扩大了医保覆盖范围，鼓励医疗服务提供者在更经济的环境下进行导管介入治疗。因此，製造商正在调整其供应链，以满足高运转率门诊中心独特的物流和库存需求。根据 HST Pathways 于 2025 年 3 月发布的《行业趋势报告》，2024 年心臟病学手术占 ASC 总手术时间利用率的 24%，这表明这些机构正在迅速转向优先开展血管介入治疗。

同时，将人工智慧 (AI) 应用于支架的选择和尺寸确定，正在提高器械植入的精准度，并革新术前规划。先进的演算法正与血管内成像工具（例如光同调断层扫瞄(OCT)）相结合，以实现病变特征和血管尺寸的自动化评估。这项技术进步解决了支架扩张不足和放置不当等关键挑战，而这些正是血管再阻塞和器械失效的主要原因。透过机器学习分析复杂的影像数据，临床医生可以高精度地确定理想的着陆区和支架尺寸，从而改善长期治疗效果。美国国立卫生研究院 (NIH) 于 2025 年 7 月发表的一篇题为《人工智慧在介入心臟病学中的应用》的综述指出，深度学习演算法能够以 94% 的准确率预测支架扩张不足，凸显了这些工具在减少手术误差方面的能力。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球血管内支架市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 类型（药物释放型支架、裸金属支架、生物可吸收支架）
  • 产品类别（冠状动脉支架、週边血管支架）
  • 依用途（医院/诊所、门诊手术中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美血管内支架市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲血管内支架市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区血管内支架市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲血管内支架市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美血管内支架市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球血管内支架市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Boston Scientific Corporation
• Medtronic plc.
• Terumo Medical Corporation
• Abbott Laboratories Inc.
• BIOTRONIK SE & Co. KG
• Stryker Corporation
• Microport Scientific Corporation
• Stentys SA
• HELLMAN & FRIEDMAN LLC
• B. Braun SE

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Intravascular Stents Market is projected to expand from a valuation of USD 13.22 Billion in 2025 to USD 20.28 Billion by 2031, registering a CAGR of 7.39% during this period. These devices, which are expandable mesh tubes utilized to reopen narrowed or blocked arteries, are essential for restoring blood flow and ensuring vessel patency. The primary growth factors include a rapidly aging global population and a growing incidence of cardiovascular diseases, which increase the necessity for interventional procedures to treat conditions like coronary artery disease. Data from the European Society of Cardiology indicates that in 2024, cardiovascular disease caused more than 3 million deaths annually across member nations, underscoring the urgent and continuing need for effective therapeutic solutions.

Conversely, the market encounters significant hurdles arising from strict regulatory frameworks regarding safety standards and product approvals. Regulatory bodies mandate exhaustive clinical testing, which prolongs development timelines and increases manufacturing costs before devices can enter the commercial market. Furthermore, the risk of product recalls triggered by adverse events, such as thrombosis, poses a serious threat to brand reputation and can delay the market adoption of emerging technologies.

Market Driver

The rising global prevalence of cardiovascular diseases acts as the main driver for the intravascular stents industry, necessitating a higher volume of angioplasty procedures to treat arterial obstructions. As poor dietary choices and sedentary lifestyles become more widespread, rates of coronary artery disease are increasing, requiring mechanical interventions to maintain adequate blood flow. According to the 'Vital Statistics Rapid Release' report published by the Centers for Disease Control and Prevention in September 2025, heart disease remained the primary cause of mortality in 2024, responsible for 683,037 deaths in the United States alone. This ongoing health burden ensures steady demand for therapeutic devices, a trend reflected in industry performance; Medtronic's 'Fiscal Year 2025 Annual Report' from June 2025 noted that their Cardiovascular Portfolio achieved $12.5 billion in net sales, highlighting the critical global need for these interventions.

Additionally, technological innovations in stent materials and design represent a significant growth driver, with manufacturers launching next-generation devices that enhance patient recovery and broaden the treatable population. Developments such as drug-eluting technologies and bioresorbable scaffolds have notably lowered the risks of thrombosis and restenosis compared to earlier bare-metal models, enabling physicians to address peripheral vascular conditions and complex lesions that were previously challenging to treat. Continuous R&D investment is generating substantial returns for major companies; for example, Abbott's 'Fourth-Quarter and Full-Year 2024 Results' from January 2025 reported a 13.7% growth in their Medical Devices segment, fueled partly by a surge exceeding 20% in Structural Heart revenue involving advanced scaffold technologies. This product evolution encourages healthcare facilities to upgrade their supplies, thereby maintaining revenue growth and market momentum.

Market Challenge

The strict regulatory frameworks that govern safety standards and product approvals constitute a major obstacle to the expansion of the Global Intravascular Stents Market. Worldwide regulatory bodies impose demanding quality assurance and clinical testing mandates that manufacturers must fulfill prior to commercializing a device. These extensive requirements significantly prolong the product development lifecycle and elevate financial costs, frequently forcing companies to divert funds away from research and development initiatives. This complicated regulatory environment slows the introduction of innovative stent technologies and limits their availability in critical geographic regions.

Data from MedTech Europe in 2024 indicates that under the new regulatory landscape, the average timeframe for medical device certification has increased to between 13 and 18 months, while compliance costs have risen by roughly 100% compared to earlier directives. These delays and increased expenses compel manufacturers to reassess their market strategies, often resulting in the withdrawal of legacy products or the deprioritization of regions with high regulatory barriers. Consequently, the sluggish approval process directly impedes market growth and restricts the timely accessibility of advanced therapeutic options for patients suffering from cardiovascular conditions.

Market Trends

The migration of procedures toward Ambulatory Surgical Centers (ASCs) is fundamentally reshaping the procurement landscape, influenced by the demand for cost-effective healthcare and evolving reimbursement policies. Healthcare systems are increasingly moving percutaneous coronary interventions (PCIs) from inpatient hospital settings to outpatient facilities to reduce procedural costs and manage hospital capacity issues. This transition is bolstered by regulatory changes, such as the broadening of CMS covered procedure lists, which encourage providers to conduct catheter-based interventions in these more economical settings; consequently, manufacturers are adjusting their supply chains to meet the specific logistical and inventory requirements of high-volume outpatient centers. According to the 'State of the Industry Report' by HST Pathways in March 2025, cardiology represented 24% of total ASC block time utilization in 2024, indicating a rapid shift toward prioritizing vascular interventions in these facilities.

Concurrently, the integration of artificial intelligence into stent selection and sizing is transforming pre-procedural planning by improving device deployment precision. Advanced algorithms are being combined with intravascular imaging tools, like Optical Coherence Tomography (OCT), to automate the assessment of lesion characteristics and vessel dimensions. This technological advancement tackles critical issues such as stent underexpansion and malapposition, which are primary causes of restenosis and device failure. By utilizing machine learning to analyze complex imaging data, clinicians can identify the ideal landing zone and stent size with superior accuracy, enhancing long-term outcomes; a review titled 'Harnessing Artificial Intelligence in Interventional Cardiology' by the National Institutes of Health in July 2025 noted that deep learning algorithms achieved 94% accuracy in predicting incomplete stent expansion, highlighting the capacity of these tools to reduce procedural errors.

Key Market Players

• Boston Scientific Corporation
• Medtronic plc.
• Terumo Medical Corporation
• Abbott Laboratories Inc.
• BIOTRONIK SE & Co. KG
• Stryker Corporation
• Microport Scientific Corporation
• Stentys S.A.
• HELLMAN & FRIEDMAN LLC
• B. Braun SE

Report Scope

In this report, the Global Intravascular Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravascular Stents Market, By Type

• Drug Eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents

Intravascular Stents Market, By Product

• Coronary Stents
• Peripheral Stents

Intravascular Stents Market, By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Intravascular Stents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravascular Stents Market.

Available Customizations:

Global Intravascular Stents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravascular Stents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents)
  • 5.2.2. By Product (Coronary Stents, Peripheral Stents)
  • 5.2.3. By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Intravascular Stents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intravascular Stents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Intravascular Stents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Intravascular Stents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End-Use

7. Europe Intravascular Stents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intravascular Stents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Intravascular Stents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Intravascular Stents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Intravascular Stents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Intravascular Stents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Intravascular Stents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intravascular Stents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Intravascular Stents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Intravascular Stents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Intravascular Stents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Intravascular Stents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Intravascular Stents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intravascular Stents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Intravascular Stents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Intravascular Stents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End-Use

10. South America Intravascular Stents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intravascular Stents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Intravascular Stents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Intravascular Stents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intravascular Stents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc.
• 15.3. Terumo Medical Corporation
• 15.4. Abbott Laboratories Inc.
• 15.5. BIOTRONIK SE & Co. KG
• 15.6. Stryker Corporation
• 15.7. Microport Scientific Corporation
• 15.8. Stentys S.A.
• 15.9. HELLMAN & FRIEDMAN LLC
• 15.10. B. Braun SE

16. Strategic Recommendations

17. About Us & Disclaimer